| Year |
Citation |
Score |
| 2023 |
Martinez HE, Marshall KE, Showell VW, Tate JE, Kirking HL, Broudy M, Matzinger SR, Burakoff A, Deng L, Payne DC, Fleming-Dutra K, Jervis RH. Evaluation of Correctional Facility COVID-19 Outbreaks With Layered Mitigation Strategies Including Vaccination: Colorado, 2020-2021. Journal of Correctional Health Care : the Official Journal of the National Commission On Correctional Health Care. PMID 36989514 DOI: 10.1089/jchc.21.12.0146 |
0.364 |
|
| 2021 |
Herlihy R, Bamberg W, Burakoff A, Alden N, Severson R, Bush E, Kawasaki B, Berger B, Austin E, Shea M, Gabrieloff E, Matzinger S, Burdorf A, Nichols J, Goode K, et al. Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1084-1087. PMID 34383734 DOI: 10.15585/mmwr.mm7032e2 |
0.303 |
|
| 2020 |
Opriessnig T, Karuppannan AK, Halbur PG, Calvert JG, Nitzel GP, Matzinger SR, Meng XJ. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge. Vaccine. PMID 31974016 DOI: 10.1016/J.Vaccine.2020.01.013 |
0.438 |
|
| 2019 |
Opriessnig T, Castro AMMG, Karuppanan AK, Gauger PC, Halbur PG, Matzinger SR, Meng XJ. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model. Vaccine. PMID 31537445 DOI: 10.1016/J.Vaccine.2019.09.029 |
0.37 |
|
| 2018 |
Cao D, Sooryanarain H, Yugo DM, Tian D, Rogers AJ, Heffron CL, Thimmasandra Narayanappa A, LeRoith T, Overend C, Matzinger SR, Elankumaran S, Hermann JR, Patterson AR, Meng XJ. Evaluation of the pathogenicity of mammalian orthoreovirus type 3 (MRV3) in germ-free gnotobiotic pigs and of the efficacy of an inactivated vaccine against MRV3 infection in neonatal conventional piglets. Veterinary Microbiology. 224: 23-30. PMID 30269786 DOI: 10.1016/J.Vetmic.2018.08.019 |
0.434 |
|
| 2018 |
Carroll TD, Jegaskanda S, Matzinger SR, Fritts L, McChesney MB, Kent SJ, Fairman J, Miller CJ. A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge. The Journal of Infectious Diseases. PMID 29701840 DOI: 10.1093/Infdis/Jiy238 |
0.773 |
|
| 2018 |
Subramaniam S, Overend C, Yugo DM, Heffron CL, Matzinger SR, Rogers AJ, Tian D, Cao QM, Kenney SP, Meng XJ. Isolation of Peripheral Blood CD8 T Cells Specific to Porcine Reproductive and Respiratory Syndrome Virus Utilizing Porcine CD137 Activation Marker. Viral Immunology. PMID 29489438 DOI: 10.1089/Vim.2017.0189 |
0.359 |
|
| 2017 |
Tian D, Sooryanarain H, Matzinger SR, Gauger PC, Karuppannan AK, Elankumaran S, Opriessnig T, Meng XJ. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus. The Journal of General Virology. PMID 29091579 DOI: 10.1099/Jgv.0.000964 |
0.625 |
|
| 2017 |
Tian D, Cao D, Lynn Heffron C, Yugo DM, Rogers AJ, Overend C, Matzinger SR, Subramaniam S, Opriessnig T, LeRoith T, Meng XJ. Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains. Vaccine. PMID 28343773 DOI: 10.1016/J.Vaccine.2017.03.046 |
0.504 |
|
| 2016 |
Opriessnig T, Xiao CT, Halbur PG, Gerber PF, Matzinger SR, Meng XJ. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. Vaccine. PMID 27919634 DOI: 10.1016/J.Vaccine.2016.11.085 |
0.383 |
|
| 2016 |
Subramaniam S, Cao D, Tian D, Cao QM, Overend C, Yugo DM, Matzinger SR, Rogers AJ, Heffron CL, Catanzaro N, Kenney SP, Opriessnig T, Huang YW, Labarque G, Wu SQ, et al. Efficient priming of CD4 T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs. Virus Research. PMID 27784629 DOI: 10.1016/J.Virusres.2016.10.007 |
0.434 |
|
| 2016 |
Matzinger SR, Opriessnig T, Xiao CT, Catanzaro N, Beach NM, Slade DE, Nitzel GP, Meng XJ. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs. Virology. 498: 82-93. PMID 27564544 DOI: 10.1016/J.Virol.2016.08.011 |
0.6 |
|
| 2015 |
Piñeyro PE, Kenney SP, Giménez-Lirola LG, Heffron CL, Matzinger SR, Opriessnig T, Meng XJ. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV. Virus Research. 210: 154-64. PMID 26239318 DOI: 10.1016/J.Virusres.2015.07.027 |
0.54 |
|
| 2015 |
Cossaboom CM, Huang YW, Yugo DM, Kenney SP, Piñeyro P, Matzinger SR, Heffron CL, Pierson FW, Meng XJ. Retraction. RNA transcripts of full-length cDNA clones of rabbit hepatitis E virus are infectious in rabbits. The Journal of General Virology. 96: 1190. PMID 26015321 DOI: 10.1099/vir.0.000114 |
0.341 |
|
| 2014 |
Subramaniam S, Piñeyro P, Tian D, Overend C, Yugo DM, Matzinger SR, Rogers AJ, Haac ME, Cao Q, Heffron CL, Catanzaro N, Kenney SP, Huang YW, Opriessnig T, Meng XJ. In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs. Vaccine. 32: 6768-75. PMID 25446829 DOI: 10.1016/J.Vaccine.2014.10.005 |
0.386 |
|
| 2014 |
Opriessnig T, Gerber PF, Xiao CT, Halbur PG, Matzinger SR, Meng XJ. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine. 32: 4342-8. PMID 24929119 DOI: 10.1016/J.Vaccine.2014.06.004 |
0.372 |
|
| 2014 |
Carroll TD, Matzinger SR, Barry PA, McChesney MB, Fairman J, Miller CJ. Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant. The Journal of Infectious Diseases. 209: 24-33. PMID 24141979 DOI: 10.1093/Infdis/Jit540 |
0.758 |
|
| 2013 |
Matzinger SR, Carroll TD, Dutra JC, Ma ZM, Miller CJ. Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells. Journal of Virology. 87: 1150-8. PMID 23152507 DOI: 10.1128/Jvi.02271-12 |
0.737 |
|
| 2011 |
Matzinger SR, Carroll TD, Fritts L, McChesney MB, Miller CJ. Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaques. Plos One. 6: e29255. PMID 22220209 DOI: 10.1371/Journal.Pone.0029255 |
0.729 |
|
| 2011 |
Carroll TD, Matzinger SR, Fritts L, McChesney MB, Miller CJ. Memory B cells and CD8⺠lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques. Plos One. 6: e21756. PMID 21747924 DOI: 10.1371/Journal.Pone.0021756 |
0.752 |
|
| 2011 |
Carroll TD, Matzinger SR, Barro M, Fritts L, McChesney MB, Miller CJ, Johnston RE. Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques. Vaccine. 29: 931-40. PMID 21111777 DOI: 10.1016/J.Vaccine.2010.11.024 |
0.747 |
|
| 2009 |
Lay M, Callejo B, Chang S, Hong DK, Lewis DB, Carroll TD, Matzinger S, Fritts L, Miller CJ, Warner JF, Liang L, Fairman J. Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection. Vaccine. 27: 3811-20. PMID 19406188 DOI: 10.1016/J.Vaccine.2009.04.054 |
0.715 |
|
| 2008 |
Carroll TD, Matzinger SR, Genescà M, Fritts L, Colòn R, McChesney MB, Miller CJ. Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. Journal of Immunology (Baltimore, Md. : 1950). 180: 2385-95. PMID 18250448 DOI: 10.4049/Jimmunol.180.4.2385 |
0.766 |
|
| Show low-probability matches. |